CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-04 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 14,000 | ||
| 2020-03-04 | Hunt Anthony Chief Executive Officer | Sale | −12,300 | $90.13 | $1.1M | 230,241 |
| 2020-03-03 | Snodgres Jon Chief Financial Officer | Sale | −610 | $88.18 | $54K | 37,172 |
| 2020-03-03 | RYAN THOMAS F JR Director | Sale | −2,225 | $85.72 | $191K | 1,923 |
| 2020-03-03 | KURIYEL RALF Senior VP, R&D | Sale | −450 | $88.35 | $40K | 29,079 |
| 2020-03-03 | Hunt Anthony Chief Executive Officer | Sale | −2,090 | $88.20 | $184K | 242,641 |
| 2020-03-03 | Hunt Anthony Chief Executive Officer | Sale | −100 | $88.56 | $9K | 242,541 |
| 2020-03-01 | Mhatre Rohin Director | Grant or award · Stock Option (Right to Buy) | +3,452 | 3,452 | ||
| 2020-02-27 | Snodgres Jon Chief Financial Officer | Grant or award | +4,686 | 37,782 | ||
| 2020-02-27 | Snodgres Jon Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | −4,571 | 4,571 | ||
| 2020-02-27 | Hunt Anthony Chief Executive Officer | Grant or award | +18,583 | 244,731 | ||
| 2020-02-27 | Hunt Anthony Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | −18,128 | 18,128 | ||
| 2020-02-27 | KURIYEL RALF Senior VP, R&D | Grant or award | +3,216 | 29,529 | ||
| 2020-02-27 | KURIYEL RALF Senior VP, R&D | Grant or award · Stock Option (Right to Buy) | +3,137 | 3,137 | ||
| 2020-02-26 | Hunt Anthony Chief Executive Officer | Sale | −1,881 | $86.86 | $163K | 227,742 |
| 2020-02-26 | Hunt Anthony Chief Executive Officer | Sale | −1,594 | $86.10 | $137K | 226,148 |
| 2020-02-26 | Snodgres Jon Chief Financial Officer | Sale | −154 | $86.86 | $13K | 32,042 |
| 2020-02-26 | Snodgres Jon Chief Financial Officer | Sale | −946 | $86.11 | $81K | 31,096 |
| 2020-02-26 | KURIYEL RALF Senior VP, R&D | Sale | −195 | $86.60 | $17K | 26,313 |
| 2020-02-25 | Hunt Anthony Chief Executive Officer | Exercise or conversion | +11,735 | $32.40 | $380K | 231,148 |
Page 39 of 42 · 832 trades